Results of a Phase II randomized trial published Online First in The Lancet, reveal that a new treatment for type 2 diabetes called TAK-875, enhances glycemic (blood sugar) control and is just as effective as the common drug treatment - sulphonylurea glimepiride. In addition, TAK-875 has less adverse effects and a considerably lower risk of hypoglycemia (low blood sugar)...
Showing posts with label Glucose. Show all posts
Showing posts with label Glucose. Show all posts
Monday, March 12, 2012
New Diabetes Drug Improves Glucose Control Without Increasing Risk Of Hypoglycemia
TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study. The results of the phase 2 randomized trial were published Online First in The Lancet...
Saturday, March 10, 2012
Improving Glucose Control Without Raising Hypoglycemia Risk, New Drug Shows Promise
Results of a Phase II randomized trial published Online First in The Lancet, reveal that a new treatment for type 2 diabetes called TAK-875, enhances glycemic (blood sugar) control and is just as effective as the common drug treatment - sulphonylurea glimepiride. In addition, TAK-875 has less adverse effects and a considerably lower risk of hypoglycemia (low blood sugar)...
New Diabetes Drug Improves Glucose Control Without Increasing Risk Of Hypoglycemia
TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study. The results of the phase 2 randomized trial were published Online First in The Lancet...
Subscribe to:
Posts (Atom)